These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 11313705

  • 1. A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines.
    Grande A, Montanari M, Manfredini R, Tagliafico E, Zanocco-Marani T, Trevisan F, Ligabue G, Siena M, Ferrari S, Ferrari S.
    Cell Death Differ; 2001 Jan; 8(1):70-82. PubMed ID: 11313705
    [Abstract] [Full Text] [Related]

  • 2. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
    Manfredini R, Trevisan F, Grande A, Tagliafico E, Montanari M, Lemoli R, Visani G, Tura S, Ferrari S, Ferrari S.
    Cancer Res; 1999 Aug 01; 59(15):3803-11. PubMed ID: 10446999
    [Abstract] [Full Text] [Related]

  • 3. Induction of retinoic acid receptor-alpha by granulocyte macrophage colony-stimulating factor in human myeloid leukemia cell lines.
    Shimizu T, Takeda K.
    Cancer Res; 2000 Aug 15; 60(16):4544-9. PubMed ID: 10969805
    [Abstract] [Full Text] [Related]

  • 4. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha.
    Gianni' M, Kalaç Y, Ponzanelli I, Rambaldi A, Terao M, Garattini E.
    Blood; 2001 May 15; 97(10):3234-43. PubMed ID: 11342454
    [Abstract] [Full Text] [Related]

  • 5. The effect pathway of retinoic acid through regulation of retinoic acid receptor alpha in gastric cancer cells.
    Liu S, Wu Q, Chen ZM, Su WJ.
    World J Gastroenterol; 2001 Oct 15; 7(5):662-6. PubMed ID: 11819850
    [Abstract] [Full Text] [Related]

  • 6. Characterization of nuclear retinoic acid binding activity in sensitive leukemic cell lines: cell specific uptake of ATRA and RAR alpha protein modulation.
    Agadir A, Cornic M, Jérôme M, Menot ML, Cambier N, Gaub MP, Gourmel B, Lefebvre P, Degos L, Chomienne C.
    Biochem Biophys Res Commun; 1995 Aug 04; 213(1):112-22. PubMed ID: 7639724
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The transcriptional corepressor CBFA2T3 inhibits all-trans-retinoic acid-induced myeloid gene expression and differentiation in acute myeloid leukemia.
    Steinauer N, Guo C, Zhang J.
    J Biol Chem; 2020 Jul 03; 295(27):8887-8900. PubMed ID: 32434928
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
    Fang Y, Zhou X, Lin M, Ying M, Luo P, Zhu D, Lou J, Yang B, He Q.
    Mol Carcinog; 2011 Jan 03; 50(1):24-35. PubMed ID: 20945414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells.
    Pisano C, Kollar P, Gianní M, Kalac Y, Giordano V, Ferrara FF, Tancredi R, Devoto A, Rinaldi A, Rambaldi A, Penco S, Marzi M, Moretti G, Vesci L, Tinti O, Carminati P, Terao M, Garattini E.
    Blood; 2002 Nov 15; 100(10):3719-30. PubMed ID: 12393712
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid.
    Iijima K, Honma Y, Niitsu N.
    Leuk Lymphoma; 2004 May 15; 45(5):1017-24. PubMed ID: 15291362
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase IV inhibition by piclamilast potentiates the cytodifferentiating action of retinoids in myeloid leukemia cells. Cross-talk between the cAMP and the retinoic acid signaling pathways.
    Parrella E, Gianni' M, Cecconi V, Nigro E, Barzago MM, Rambaldi A, Rochette-Egly C, Terao M, Garattini E.
    J Biol Chem; 2004 Oct 01; 279(40):42026-40. PubMed ID: 15292163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.